Author:
Winslow Monte M.,Dayton Talya L.,Verhaak Roel G. W.,Kim-Kiselak Caroline,Snyder Eric L.,Feldser David M.,Hubbard Diana D.,DuPage Michel J.,Whittaker Charles A.,Hoersch Sebastian,Yoon Stephanie,Crowley Denise,Bronson Roderick T.,Chiang Derek Y.,Meyerson Matthew,Jacks Tyler
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Rodenhuis, S. et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 48, 5738–5741 (1988)
2. Takahashi, T. et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491–494 (1989)
3. Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nature Genet. 29, 418–425 (2001)
4. Jackson, E. L. et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 65, 10280–10288 (2005)
5. Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243–3248 (2001)
Cited by
371 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献